Courses

This face to face course led by the regional Children's Holistic Integrated Palliative Care Service (CHIPS) is designed to support staff working in hospices caring for children across the North East and North Cumbria.

This interactive one day course allows paediatric staff to gain an awareness of the anatomy and physiology of the paediatric airway, general care and management of patients who require a tracheostomy, from the insertion of a tracheostomy to discharge home and de-cannulation.

The 4Ps Programme has been developed by research active healthcare professionals in Newcastle and is designed to support colleagues' needs no matter where they are on the “research interested” to “Aspiring Clinical Academic” continuum

Haematological cancers differ from solid tumours in many ways: in the mutations that drive them, their interactions with their environment, and the treatments that are effective against them. This course introduces the biology, behaviours and genetics of this diverse group of diseases with a focus on the features we can now target and the mechanisms of action of the various treatments

Please note our Leading an Empowered Organisation™ (LEO) programme is a development opportunity for nursing, midwifery and allied health professional (NMAHP) staff working at Newcastle Hospitals only

Benign Paroxysmal Positional Vertigo (BPPV) is one of the most common causes of dizziness and imbalance, significantly increasing fall risk - especially in older adults. Join our hands on practical course to help you demystify the physiology and management of BPPV with a focus on practical skills and case scenarios to help you to gain confidence to assess and treat patients.

Please note our Leading an Empowered Organisation™ (LEO) programme is a development opportunity for nursing, midwifery and allied health professional (NMAHP) staff working at Newcastle Hospitals only

During this introduction to the science behind a wide variety of systemic treatments given to people with prostate, bladder, or kidney cancer, Dr Elaine Vickers will discuss current hormone therapies, immunotherapy and targeted treatments.

A focus on modern systemic treatments for non-small cell lung cancer (NSCLC) as well as the gene faults that drive many NSCLCs; the targeted treatments that exploit these faults, such as inhibitors of EGFR, ALK, ROS1, B-Raf, HER2, MET, and RET; the immune system and checkpoint inhibitor group of immunotherapies, including PD-1, PD-L1 and CTLA-4 targeted antibody therapies